09 - Referências Bibliográficas

Equipe Editorial Bibliomed

Um asterisco(*) denota um item que foi particularmente proveitoso na preparação desta pesquisa de Population Reports.

1. ADINMA, J.I. and OKEKE, A.O. The pill: Perceptions and usage among Nigerian students. Advances in Contraception 9(4): 341-349. Dec. 1993.

2. AKHTER, H. A special obligationAccess to contraception. Network 13(3): 4-5. Research Triangle Park, North Carolina, Family Health International. Mar. 1993.

3. AKHTER, H.H., CHOWDHURY, M.E.E.K., RAHMAN, M.H., and HUSSAIN, M.A.I. Report on a study to compare compliance, continuation and failure rates and reported side effects of low dose and standard dose oral pill in rural Bangladesh. Dhaka, Bangladesh Institute of Research for Promotion of Essential and Reproductive Health and Technologies, Apr. 1996. 110 p.

*4. ALI, M. and CLELAND, J. Contraceptive discontinuation in six developing countries: A cause-specific analysis. International Family Planning Perspectives 21(3): 92-97. Sep. 1995.

5. ALI, N., WELLS, E., and SUTTON, D. Reviewing print material for oral contraceptives: Direction for the future. Washington, D.C., Program for Appropriate Technology in Health, Jul. 9, 1998. 70 p.

6. AMERICAN HEALTH CONSULTANTS (AHC). Prepare family planning patients for successful pill-taking. Contraceptive Technology Update 19(4): 45-47. Atlanta, Georgia, AHC. Apr. 1998.

7. ANGLE, M., HUFF, P.S., and LEA, J.W. Interactions between oral contraceptives and therapeutic drugs. Outlook 9(1): 1-6. Apr. 1991.

8. ANGLE, M. (INTRAH/PRIME) [Making up missed pills] Personal communication, Jun. 2000.

9. ARMSTRONG, J.L., REID, M., and BIGRIGG, A. Scare over oral contraceptives. Effect on behaviour of women attending a family planning clinic [letter]. British Medical Journal 311(7020): 1637. Dec. 16, 1995.

10. BACK, D.J. and ORME, M.L. Pharmacokinetic drug interactions with oral contraceptives. Clinical Pharmacokinetics 18(6): 472-484. Jun. 1990.

11. BACK, D.J., TIJA, J., MARTIN, C., MILLAR, E., MANT, T., MORRISON, P., and ORME, M. The lack of interaction between temafloxacin and combined OC steroids. Contraception (43): 317-323. 1991.

12. BARDITCH-CROVO, P., TRAPNELL, C.B., ETTE, E., ZACUR, H.A., CORESH, J., ROCCO, L.E., HENDRIX, C.W., and FLEXNER, C. The effects of rifampicin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clinical Pharmacology and Therapeutics 65(4): 428-438. 1999.

13. BARNETT, B. Fertility awareness benefits couples. Network 17(1): 4-8. Family Health International. Fall 1996.

14. BARNETT, B. Zimbabwe's “clinics under trees” increase access. Network 17(2): 15-16. Family Health International. Spring 1999.

15. BEKSINSKA, M.E., REES, V.H., NKONYANE, T., and MCINTYRE, J.A. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg. British Journal of Family Planning 24(1): 21-23. Apr. 1998.

16. BLACKBURN, R., CUNKELMAN, J.A., and ZLIDAR, V.M. Oral contraceptives: An update. Population Reports, Series A, No. 9. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Spring 2000. 39 p.

17. BORODITSKY, R., FISHER, W., and SAND, M. The 1995 Canadian Contraception Study. Journal of the Society of Obstetricians and Gynecologists of Canada (Special Suppl.): 1-31. Dec. 1996.

18. BRADLEY, J. Using COPE to improve quality of care: The experience of the Family Planning Association of Kenya. Quality/Calidad/Qualité, No. 9. Population Council, 1998. p. 1-24.

19. BROMHAM, D.R. and CARTMILL, R.S.V. Knowledge and use of secondary contraception among patients requesting termination of pregnancy. British Medical Journal 306(6877): 556-557. Feb. 27, 1993.

20. BROOK, S.J. and SMITH, C. Do combined oral contraceptive users know how to take their pills correctly? British Journal of Family Planning 17(1): 18-20. Apr. 1991.

21. CANALES, J.R.L., CARCAMO, J.A., GALINDO, J., VERNON, R., and BRAMBILA, C. Reproductive health and prenatal care. Washington, D.C., Population Council, Apr. 30, 1995. (INOPAL II: Final technical report) 74 p. (Unpublished).

22. CASTLE, S., KONATÉ, M.K., ULIN, P.R., and MARTIN, S. Clandestine contraceptive use in urban Mali. Studies in Family Planning 30(3): 231-248. Sep. 1999.

23. CENTRAL BUREAU OF STATISTICS, STATE MINISTRY OF POPULATION/NATIONAL FAMILY PLANNING COORDINATION BOARD, MINISTRY OF HEALTH, and MACRO INTERNATIONAL (MI). Indonesia Demographic and Health Survey, 1994. Calverton, Maryland, MI, Oct. 1995. 366 p.

24. CENTRAL BUREAU OF STATISTICS, STATE MINISTRY OF POPULATION/NATIONAL FAMILY PLANNING COORDINATION BOARD, MINISTRY OF HEALTH, AND MACRO INTERNATIONAL (MI). Indonesia Demographic and Health Survey, 1997. Calverton, Maryland, MI, Oct. 1998. 324 p.

25. CHASAN-TABER, L., WILLETT, W.C., STAMPFER, M.J., HUNTER, D.J., COLDITZ, G.A., SPIEGELMAN, D., and MANSON, J.E. A prospective study of oral contraceptives and NIDDM among U.S. women. Diabetes Care 20(3): 330-335. Mar. 1997.

26. CHILD, T.J., MACKENZIE, I.Z., and REES, M. Terminations of pregnancy, not unplanned deliveries, increased as result of pill scare [letter]. British Medical Journal 313(7063): 1005. Oct 19, 1996.

27. CHILD, T.J., REES, M., and MACKENZIE, I.Z. Pregnancy terminations after oral contraception scare [letter]. Lancet 347(9010): 1260-1261. May 4, 1996.

28. COEYTAUX, F.M. and ALLINA, A. The pill without prescription: The international experience. In: Samuels, S.E. and Smith, M.D., eds. The Pill: From Prescription to Over the Counter. Menlo Park, California, Kaiser Family Foundation. 1994. p. 41-51.

29. COGGINS, C., LANGER, A., WINIKOFF, B., LAZCANO, E.C., HEIMBURGER, A., and SLOAN, N. Effectiveness of integration of self-screening of STDs into family planning programs. Presented at the American Public Health Association 126th Annual Meeting, Washington, D.C., Nov 15-18, 1998.

30. CNN. No prescription for the Pill? FDA considers making the pill available over-the-counter. CNN.com. Jun. 29, 2000.

31. CONNELL, E.B. Patient counseling. Advances in Contraception 8(Suppl. 1): 67-73. Oct. 1992.

32. COTE, J. Interaction of griseofulvin and oral contraceptives. Journal of the American Academy of Dermatology 22(1): 124-125. Jan. 1990.

33. COTTEN, N., STANBACK, J., MAIDOUKA, H., TAYLOR-THOMAS, J.T., and TURK, T. Early discontinuation of contraceptive use in Niger and The Gambia. International Family Planning Perspectives 18(4): 145-149. Dec. 1992.

34. CRAWFORD, P., CHADWICK, D.J., MARTIN, C., TJIA, J., BACK, D.J., and ORME, M. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. British Journal of Clinical Pharmacology 30(6): 892-896. Dec. 1990.

35. CSEMICZKY, G., ALVENDAL, C., and LANDGREN, B.M. Risk for ovulation in women taking a low-dose OC (Microgynon) when receiving antibacterial treatment with fluoroquinolone (ofloxacin). Advances in Contraception 12(2): 101-109. Jun. 1996.

36. CURTIS, S.L. and BLANC, A.K. Determinants of contraceptive failure, switching and discontinuation: An analysis of DHS contraceptive histories. Calverton, Maryland, Macro International, Oct. 1997. (DHS Analytical Reports No. 6) 50 p.

37. DARNEY, P.D. OC practice guidelines: Minimizing side effects. International Journal of Fertility and Women's Medicine 42(Suppl. 1): 158-169. 1997.

38. DAVIS, A. and WYSOCKI, S. Clinician/patient interaction: Communicating the benefits and risks of oral contraception. Contraception 59(1 Suppl.): 39S-42S. Jan. 1999.

39. DE BOER, A. and HERINGS, R.M. Oral contraceptives without prescription [letter]. Lancet 342(8877): 993. Oct. 16, 1993.

40. DEIJEN, J.B. and KORNAAT, H. The influence of type of information, somatization, and locus of control on attitude, knowledge, and compliance with respect to the triphasic oral contraceptive Tri-Minulet. Contraception 56(1): 31-41. Jul. 1997.

41. DEPARTMENT OF NATIONAL HEALTH AND POPULATION DEVELOPMENT, S.A. Annual report on family planning statistics 1992-1993. Department of National Health and Population Development, South Africa, 1993.

42. DEVENPORT, M.H., CROOK, D., WYNN, V., and LEES, L.J. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives. British Journal of Clinical Pharmacology (27): 851-859. 1989.

43. DILLNER, L. Pill scare linked to rise in abortions. British Journal of Medicine 312(7037): 996. Apr. 20, 1996.

44. DONLEY, T.G., SMITH, R.F., and ROY, B. Reduced oral contraceptive effectiveness with concurrent antibiotic use: A protocol for prescribing antibiotics to women of childbearing age. Compendium 11(6): 392-396. Jun. 1990.

45. DOUCOURE, A., DJENEBA, D., TOURE, F., TRAORE, A., DOUMBIA, S., SANOGO, D., HUNTINGTON, D., and VIADRO, C. The effect of a family planning CBD project in Mali. In: Foreit, J.R. and Frejka, T., eds. Family Planning Operations Research: A Book of Readings. New York, Population Council. 1998. p. 115-120.

46. DRENNAN, M. Reproductive health: New perspectives on men's participation. Population Reports, Series J, No. 46. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Oct. 1998. 36 p.

47. DUNCAN, G., HARPER, C., ASHWELL, E., MANT, D., BUCHAN, H., and JONES, L. Termination of pregnancy: Lessons for prevention. British Journal of Family Planning 15(4): 112-117. Jan. 1990.

48. ELOMAA, K., ROLLAND, R., BROSENS, I., MOORREES, M., DEPREST, J., TUOMINEN, J., and LÄHTEENMÄKI, P. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. American Journal of Obstetrics and Gynecology 179(1): 41-46. Jul. 1998.

49. ENTWISLE, B., RINDFUSS, R.R., WALSH, S.J., EVANS, T.P., and CURRAN, S.R. Geographic information systems, spatial network analysis, and contraceptive choice. Demography 34(2): 171-187. May 1997.

50. ENÜNLÜ, T. and DOGAN, B.G. Contraceptive use dynamics in Turkey. In: Akin, A. and Bertan, M., eds. Contraception, Abortion, and Maternal Health Services in Turkey: Results of Further Analysis of the 1993 Turkish Demographic and Health Survey. 1996. Calverton, Maryland, Macro International. p. 13-65.

51. FAMILY HEALTH INTERNATIONAL (FHI). Checklist for clients who want to initiate combined oral contraceptives (COCs) in community-based services (CBS). FHI (Website). http://www.fhi.org/en/fp/checklistse/chklstfpe/cocchkl.html. Oct 8, 1999.

52. FAMILY HEALTH INTERNATIONAL (FHI). Checklist to rule out pregnancy for non-menstruating family planning clients. FHI (Website). http://www.fhi.org/en/fp/checklistse/chklstfpe/pregckl.html. Oct 8, 1999.

53. FAMILY HEALTH INTERNATIONAL (FHI). Pregnancy-related morbidities affect millions. Research Triangle Park, North Carolina, FHI, Feb. 15, 1994. 2 p.

54. FAMILY PLANNING LOGISTICS MANAGEMENT (FPLM)/JOHN SNOW, INC. (JSI). Programs that deliver: Logistics' contributions to better health in developing countries. Arlington, Virginia, FPLM/JSI, 2000. 117 p.

55. FAMILY PLANNING NEWS. Assurance on safety of contraceptive pill: Weighed in the balances?And found beneficial. Family Planning News, Vol. 21 No. 2. 1996. p. 4. (Report on the 4th Congress of the European Society of Contraception, Barcelona, Italy)

56. FAMILY PLANNING SERVICE EXPANSION AND TECHNICAL SUPPORT (SEATS II) Project. Mainstreaming quality improvement in family planning and reproductive health services delivery: Context and case studies. Arlington, Virginia, John Snow, Inc., Jan. 2000. 93 p.

57. FARRELL, B., SOLTER, C., and HUBER, D. Comprehensive reproductive health and family planning training curriculum: Module 5: Emergency contraceptive pills. Pathfinder International (Website). http://www.pathfind.org/html/mod_links.htm. Nov. 1997.

58. FATHONAH, S. Contraceptive use dynamics in Indonesia. Calverton, Maryland, Macro International, Jul. 1996. (Demographic and Health Surveys Working Paper No. 20) 31 p.

59. FINGER, W.R. Using oral contraceptives correctly: Progress on package instructions. Network 12(2): 14-17, 27. Research Triangle Park, North Carolina, Family Health International. Sep. 1991.

60. FINGER, W.R. Oral contraceptives are safe, very effective. Network 16(4): 4-8. Research Triangle Park, North Carolina, Family Health International. Summer 1996.

61. FINGER, W.R. Commercial sector can improve access. Network 18(2): 12-15. Research Triangle Park, North Carolina, Family Health International. Winter 1998.

*62. FONTAINE, A., POTTER, L., and VENEY, J.E. Use-effectiveness of oral contraceptives and quality of care. Apr. 25, 1993. 28 p. (Unpublished).

63. FOTHERBY, K. Interactions with oral contraceptives. American Journal of Obstetrics and Gynecology 163(6 Pt. 2): 2153-2159. Dec. 1990.

64. FRIEDMAN, C.I., HUNEKE, A.L., KIM, H.M., and POWELL, J. The effect of ampicillin on oral contraceptive effectiveness. Obstetrics and Gynecology (164): 33-37. 1980.

65. GANDOTRA, M.M. and DAS, N.P. Factors influencing choice of a contraceptive and the reasons for its discontinuation. In: Khan, M.E. and Cernada, G., eds. Spacing as an Alternative Strategy: India's Family Welfare Programme. New Delhi, BR Publishing Corporation. 1996. p. 95-114.

66. GARG, S.K., CHASE, H.P., MARSHALL, G., HOOPS, S.L., HOLMES, D.L., and JACKSON, W.E. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. Journal of the American Medical Association 271(14): 1099-1102. Apr. 13, 1994.

67. GLASIER, A. Safety of emergency contraception. Journal of the American Medical Women's Association 53(5): 219-221. Fall 1998.

68. GRIFFEY BRECHIN, S.J., SULLIVAN, R., SMITH, T., and LACOSTE, M. Improving performance of healthcare providers through structured on-the-job training: A pilot test in Zimbabwe and Kenya. Baltimore, Johsn Hopkins International Education and Training in Reproductive Health, Mar. 1999. (No. JHP-04) 32 p.

69. GRIMES, D.A. Over-the-counter oral contraceptives?An immodest proposal? [editorial]. American Journal of Public Health 83(8): 1092-1094. Aug. 1993.

70. GRIMES, D.A. A guest editorial: Over-the-counter oral contraceptives: An idea whose time has not quite come [editorial]. Obstetrical and Gynecological Survey 50(6): 411-412. Jun. 1995.

71. GUILLEBAUD, J. Practical prescribing of the combined oral contraceptive pill. Unpublished, 1989. 25 p.

*72. GUILLEBAUD, J. The Pill. 5th ed. London, Oxford Univ. Press, 1997. 288 p.

*73. GUILLEBAUD, J. The Pill and Other Forms of Hormonal Contraception. 5th ed. Oxford, Oxford University Press, 1997. 320 p.

74. GUILLEBAUD, J. (Margaret Pyke Family Planning Centre) [Comments on draft report, “Helping women use the pill”] Personal communication, May 24, 2000.

75. GUILLEBAUD, J. Contraception Today: A pocketbook for General Practitioners. 4th ed. London, Martin Dunitz, Jun. 2000. 120 p.

76. GUILLEBAUD, J. Will the pill become obsolete in this century? Family Planning Perspectives 32(2): 93-95. Mar./Apr. 2000. (Available: http://www.agi-usa.org/pubs/journals/3209300.html#1)

77. GUPTA, A., CHOUDHURY, B.R., and BALACHANDRAN, I. Touch me, touch-me-not: Women, plants and healing. In: Women's Beliefs about Disease and Health: Kali for Women. 1997. p. 66-91.

78. HA, P.T.T., HANH, L.T., DUNG, N.T.K., SA, N.T., and SCHULER, S.R. Reproductive tract infections and contraceptive method choice: Findings from a qualitative study in Vietnam. 1999. 18 p. (Unpublished).

79. HALPERIN, E.C. Oral contraceptives as over-the-counter medication. North Carolina Medical Journal 55(5): 183-186. May 1994.

80. HARDEE, K., CLYDE, M., MCDONALD, O.P., BAILEY, W., and VILLINSKI, M.T. Assessing family planning service-delivery practices: The case of private physicians in Jamaica. Studies in Family Planning 26(6): 338-349. Nov./Dec. 1995.

81. HARDEE, K., JANOWITZ, B., STANBACK, J., and VILLINSKI, M.T. What have we learned from studying changes in service delivery guidelines and practices? International Family Planning Perspectives 24(2): 84-90. Jun. 1998. (Available: http://www.agi-usa.org/pubs/journals/2408498.html, Accessed Aug. 13, 1999)

82. HARVEY, P.D. 1991 Contraceptive social marketing statistics. Washington, D.C., DKT International, Jun. 1992. 6 p.

83. HARVEY, P.D. 1998 Contraceptive social marketing statistics. Washington, D.C., DKT International, Sep. 1999. 8 p.

*84. HATCHER, R.A. and GUILLEBAUD, J. The pill: Combined oral contraceptives. In: Hatcher, R.A., Trussell, J., Stewart, F., Cates Jr., W., Stewart, G.K., Guest, F., and Kowal, D. Contraceptive Technology. 17th ed. New York, Ardent Media. 1998. p. 405-466.

*85. HATCHER, R.A., RINEHART, W., BLACKBURN, R., GELLER, J.S., and SHELTON, J.D. The Essentials of Contraceptive Technology. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Jul. 1997. 340 p.

86. HAVANON, N., KANCHANASINITH, K., POTTER, L., and CAÑAMAR, R. Thailand: Study of pill compliance among drugstore purchasers. Bangkok, Oct. 1992. 42 p.

87. HELZNER, J.F., CARAM, M., CORDERO, M., and SANGIOVANNI, G. Assessing strategies to promote high quality care: The case of PROFAMILIA, Dominican Republic. Presented at the American Public Health Association 118th Annual Meeting, New York, Sep. 30ÄOct. 4, 1990. International Planned Parenthood Federation, PROFAMILIA. Oct. 1990. 10 p.

88. HILLARD, P.J. Oral contraception noncompliance: The extent of the problem. Advances in Contraception 8(Suppl. 1): 13-20. Oct. 1992.

89. HILLARD, P.J. Family planning in the teen population. Current Opinion in Obstetrics and Gynecology 5(6): 798-804. Dec. 1993.

90. HODGINS, S. Contraceptive use and beliefs among women in rural Togo. 1999.

91. HOSSAIN, M.B. and PHILLIPS, J.F. The impact of outreach on the continuity of oral contraceptive use in rural Bangladesh. Studies in Family Planning 27(2): 98-106. Mar./Apr. 1996.

92. HOUGHTON, A. Oral contraceptives without prescription [letter]. Lancet 342(8877): 993. Oct. 16, 1993.

93. HUBACHER, D., GOCO, N., GONZALEZ, B., and TAYLOR, D. Factors affecting continuation rates of DMPA. Contraception 60(345-351). 1999.

*94. HUBACHER, D. and POTTER, L. Adherence to oral contraceptive regimens in four countries. International Family Planning Perspectives 19(2): 49-53. Jun. 1993.

95. HUEZO, C. and CARIGNAN, C.S. Medical and service delivery guidelines for family planning. 2nd ed. International Planned Parenthood Federation (IPPF) Medical Publications. London, IPPF, World Health Organization, and AVSC International, 1997. 298 p.

96. HUEZO, C. and MALHOTRA, U. Choice and use-continuation of methods of contraception: A multicentre study. London, International Planned Parenthood Federation, 1993. 163 p.

97. HUNTINGTON, D. and APLOGAN, A. The integration of family planning and childhood immunization services in Togo. Studies in Family Planning 25(3): 176-183. May/Jun. 1994.

98. HUNTINGTON, D., HASSAN, E.O., ATTALLAH, N., TOUBIA, N., NAGUIB, M., and NAWAR, L. Improving the medical care and counseling of postabortion patients in Egypt. Studies in Family Planning 26(6): 350-362. Nov./Dec. 1995.

99. INDONESIA NATIONAL FAMILY PLANNING COORDINATING BOARD (BKKBN). The operational aspect of population and family planning program implementation. BKKBN (Website). http://www.bkkbn.go.id/english/c.htm. Undated.

100. INTERNATIONAL WORKING GROUP ON ENHANCING PATIENT COMPLIANCE AND ORAL CONTRACEPTIVE EFFICACY. A consensus statement: Enhancing patient compliance and oral contraceptive efficacy. British Journal of Family Planning (18): 126-129. 1993.

101. IVERSEN, O.E. and NILSEN, S.T. The recent pill scare and number of legal abortions in Norway. Acta Obstetricia et Gynecologica Scandinavica 75(7): 690-691. Aug. 1996.

102. JAIN, A. Should eliminating unmet need for contraception continue to be a program priority? International Family Planning Perspectives 25(Suppl.): S39-S43, S49. Jan. 1999.

103. JOHNS HOPKINS CENTER FOR COMMUNICATION PROGRAMS/POPULATION COMMUNICATION SERVICES (JHU/PCS). New research documents success of Johns Hopkins GATHER counseling for family planning. JHU/PCS (Website). http://www.jhuccp.org/news/020899.stm. Feb. 8, 1999.

104. JOHNS HOPKINS CENTER FOR COMMUNICATION PROGRAMS/POPULATION COMMUNICATION SERVICES (JHU/PCS). Nepal's radio communication project. JHU/PCS (Website). http://www.jhuccp.org/ee/jan14.stm. 2000.

105. JOHNS HOPKINS CENTER FOR COMMUNICATION PROGRAMS/POPULATION COMMUNICATION SERVICES (JHU/PCS). Scripts from Nepal radio show, “Cut Your Coat According to Your Cloth.” Baltimore, JHU/PCS, 2000.

106. JOHNS HOPKINS CENTER FOR COMMUNICATION PROGRAMS/POPULATION COMMUNICATION SERVICES (JHU/PCS). Scripts from Nepal radio show, “Service Brings Rewards.” Baltimore, JHU/PCS, 2000.

107. JOHNS HOPKINS PROGRAM FOR INTERNATIONAL TRAINING IN REPRODUCTIVE HEALTH (JHPIEGO). Performance improvement process. JHPIEGO (Website). http://www.reproline.jhu.edu/english/3improve/3process/3pi.htm. Jan. 20, 1999.

108. JONES, E.F. Accessibility as a determinant of contraceptive method choice. In: Bulatao, R.A., Palmore, J.A., and Ward, S.E., eds. Choosing a Contraceptive: Method Choice in Asia and the United States. Boulder, Colorado, Westview Press. 1989. p. 57-77.

109. KANE, T.T., GAMINIRATNE, K.H.W., and STEPHEN, E.H. Contraceptive method switching in Sri Lanka: Patterns and implications. International Family Planning Perspectives 14(2): 68-75. Jun. 1988. 110. KELLER, S. Better communication improves OC use. Network 16(4): 10-13. Research Triangle Park, North Carolina, Family Health International. Summer 1996.

111. KILLICK, S.R. Patient education and understanding: A critical review. Advances in Contraception 8(Suppl. 1): 57-65. Oct. 1992.

112. KILLICK, S.R., BANCROFT, K., OELBAUM, S., MORRIS, J., and ELSTEIN, M. Extending the duration of the pill-free interval during combined oral contraception. Advances in Contraception 6(1): 33-40. Mar. 1990.

113. KINCAID, D.L. Social networks, ideation, and contraceptive behavior in Bangladesh: A longitudinal analysis. Social Science and Medicine 50(2): 215-231. Jan. 2000.

114. KNAUFF, J., MUHUHU, P., and YUMKELLA, F. Improving service access in the mountains of the moon. Chapel Hill, North Carolina, Program for International Training in Health, 1994. 6 p.

115. KNOWLES, J. and RINGEL, M. All About Birth Control: The Complete Guide. Issued by Planned Parenthood Federation of America. New York, Three Rivers Press, 1998. 240 p.

116. KOLS, A. and SHERMAN, J.E. Family planning programs: Improving quality. Series J, No. 47. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Nov. 1998. 40 p.

117. KONTULA, O. and HAAVIO-MANNILA, E. Finland. In: Francoeur, R.T., ed. The International Encyclopedia of Sexuality. Vol. 1. New York, Continuum. 1997. p. 419-491.

*118. KORVER, T., GOORISSEN, E., and GUILLEBAUD, J. The combined oral contraceptive pill: What advice should we give when tablets are missed? British Journal of Obstetrics and Gynaecology 102(8): 601-607. Aug. 1995.

119. KOST, K. The dynamics of contraceptive use in Peru. Studies in Family Planning 24(2): 109-119. Mar./Apr. 1993.

120. KOVACS, G.T. and MURTAGH, J. Survey of general practitioner instructions to oral contraceptive users. Australian Family Physician 23(5): 915-918. May 1994.

121. LANDGREN, B.M. and CSEMICZKY, G. The effect on follicular growth and luteal function of “missing the pill.” A comparison between a monophasic and a triphasic combined oral contraceptive. Contraception 43(2): 149-159. Feb. 1991.

122. LANDGREN, B.M. and DICZFALUSY, E. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. Contraception 29(5): 437-446. 1984.

123. LARSON, A., ISLAM, S., and MITRA, S.N. Pill use in Bangladesh: Compliance, continuation and unintentional pregnancies. Report on the 1990 pill use study. Dhaka, Mitra and Associates, Jul. 1991. 70 p.

124. LAWRENCE, H. How early-cycle side effects discourage pill use. Contemporary Ob/Gyn 42(9): 45-49, 52, 55-59. Sep. 1997.

125. LEBEL, M., MASSON, E., GUILBERT, E., COLBORN, D., PAQUET, F., ALLARD, S., VALLEE, F., and NARANG, P.K. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone. Journal of Clinical Pharmacology 38(11): 1042-1050. Nov. 1998.

126. LEI, Z.-W., WU, S.C., GARCEAU, R.J., JIANG, S., YANG, Q.-Z., WANG, W.-L., and VANDER MEULEN, T.C. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception (53): 357-361. 1996.

127. LETTERIE, G.S. and CHOW, G.E. Effect of “missed” pills on oral contraceptive effectiveness. Obstetrics and Gynecology 79(6): 979-982. Jun. 1992.

128. LEWIS, G.L. and LISKIN, L.S. Perceptions of oral contraceptives: Pretest results of new package label. Baltimore, Johns Hopkins School of Public Health, Population Communication Services, May 1997. 111 p.

129. LOZA, S.F., SAYED, H.A.A., and POTTER, L.S. Oral contraceptive compliance and continuation in Egypt: Complementary findings of EDHS (1988) and focus group research. Cairo, Cairo Demographic Center, 1991. (Working Paper No. 22) 24 p.

130. MAGGIOLI, F., PURICELLI, G., DOTTORINI, M., CAPRIOLI, S., BIANCHI, W., and SUTER, F. The effect of ciprofloxacin on oral contraceptive steroid treatments. Drugs Under Experimental and Clinical Research 17(9): 451-454. 1991.

131. MANAGEMENT SCIENCES FOR HEALTH (MSH) FAMILY PLANNING MANAGEMENT DEVELOPMENT, ED. MILLER, J., SERIES ED. Improving contraceptive supply management. Family Planning Manager, Boston, MSH, Vol. 1 Sep./Oct. 1992. 20 p.

132. MCCAULEY, A., ROBEY, B., BLANC, A., and GELLER, J. Opportunities for women through reproductive choice. Population Reports, Series M, No. 12. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Jul. 1994. 39 p.

133. MELIÁN, M.M. La dinámica del uso de la anticoncepción en Paraguay: Un análisis de discontinuación, falla, y cambio de métodos con tablas de vida. [SPA] [Contraceptive use dynamics in Paraguay: A life-table analysis of discontinuation, failure, and switching]. Calverton, Maryland, Macro International, Jun. 1994. (Seminario sobre la Dinamica Anticonceptiva en America Latina)

134. MENSCH, B.S., BRUCE, J., and GREENE, M.E. The uncharted passage: Girls' adolescence in the developing world. Population Council, 1998. 115 p.

135. MILLER, C. The combined oral contraceptive. A practical guide. Australian Family Physician 19(6): 897, 900-906. Jun. 1990.

136. MILLER, C. and MURTAGH, J. Combined oral contraception. Australian Family Physician 21(12): 1787-1788. Dec. 1992.

137. MILLER, K., MILLER, R., and FASSIHIAN, G. How do providers restrict access to family planning methods? Population Council, 1998. (Unpublished).

138. MILLER, K., MILLER, R., and KOTKIN, D.J. Quality of care in African family planning programs: A survey of findings from situation analysis studies. New York, Population Council, Sep. 1995. 19 p.

139. MITRA, S.N. and AL-SABIR, A. Contraceptive use dynamics in Bangladesh. Calverton, Maryland, Macro International, Oct. 1996. (DHS Working Papers No. 21) 28 p.

140. MOLLOY, B.G., COULSON, K.A., LEE, J.M., and WATTERS, J.K. “Missed pill” conception: Fact or fiction? British Journal of Medicine 290(6480): 1474-1475. May 18, 1985.

*141. MORENO, L. and GOLDMAN, N. Contraceptive failure rates in developing countries: Evidence from the Demographic and Health Surveys. International Family Planning Perspectives 17(2): 44-49. Jun. 1991.

142. MURPHY, A.A., ZACUR, H.A., CHARACE, P., and BURKMAN, R.T. The effect of tetracycline on level of oral contraceptives. American Journal of Obstetrics and Gynecology (164): 28-33. 1991.

143. MURPHY, E. and STEELE VERME, C. Client-provider interactions in family planning services: Guidance from research and program experience. In: Technical Guidance/Competence Working Group. Recommendations for updating selected practices in contraceptive use: Volume II. Chapel Hill, North Carolina, Sep. 1997. p. 187-194.

144. MURRAY, C.J.L. and LOPEZ, A.D. The global burden of disease in 1990s: Final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-wights, and disability weights. In: Murray, C.J.L. and Lopez, A.D., eds. The Global Burden of Disease. The Global Burden of Disease and Injury Series. Vol. 1. Boston, Massachusetts, Harvard University Press. 1996. p. 247-293.

145. NEELY, J.L., ABATE, M., SWINKER, M., and D'ANGIO, R. The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone. Obstetrics and Gynecology 77(3): 416-420. Mar. 1991.

*146. OAKLEY, D. Rethinking patient counseling techniques for changing contraceptive use behavior. American Journal of Obstetrics and Gynecology 170(3, Pt. 2): 1585-1590. May 1994.

147. OAKLEY, D., POTTER, L., DE LEON-WONG, E., and VISNESS, C. Oral contraceptive use and protective behavior after missed pills. Family Planning Perspectives 29(6): 277-279, 287. Nov./Dec. 1997.

148. OAKLEY, D., SEREIKA, S., and BOGUE, E.L. Oral contraceptive pill use after an initial visit to a family planning clinic. Family Planning Perspectives 23(4): 150-154. Jul./Aug. 1991.

149. ORDÓÑEZ GÓMEZ, M. La dinamica anticonceptiva en Colombia: discontinuacion del uso de metodos anticonceptivos, cambio y tasas de falla de los metodos. [SPA] [Contraceptive dynamics in Colombia: discontinuation of contraceptive methods, change, and failure rates]. Calverton, Maryland, Macro International, Jun. 1994. (Seminario sobre la Dinamica Anticonceptiva en America Latina) 26 p.

150. OSLER, M. and RIPHAGEN, F.E. Contraception survey: Denmark 1988. Contraception 42(5): 507-521. Nov. 1990.

151. OTTOLENGHI, E. (Population Council) [Increasing pill access] Personal communication, May 15, 2000.

152. PADILLA, A. La dinámica del uso de la anticoncepción en el Perú: Un análisis de discontinuación, falla, y cambio de métodos. [SPA] [Contraceptive use dynamics in Peru: An analysis of discontinuation, failure, and switching]. Calverton, Maryland, Macro International, Jun. 1994. (Seminario sobre la Dinamica Anticonceptiva en America Latina)

153. PEREZ, A. and TABIJE, T.L. Contraceptive discontinuation, failure, and switching behavior in the Philippines. Calverton, Maryland, Macro International, Apr. 1996. (DHS Working Papers No. 18) 25 p.

154. PETERSEN, K.R., SKOUBY, S.O., SIDELMANN, J., MOLSTED-PEDERSEN, L., and JESPERSEN, J. Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. American Journal of Obstetrics and Gynecology 171(2): 400-405. Aug. 1994.

155. PHILLIPS, J.F., HOSSAIN, M.B., and ARENDS-KUENNING, M. The long-term demographic role of community-based family planning in rural Bangladesh. Studies in Family Planning 27(4): 204-219. Jul./Aug. 1996.

156. PIOTROW, P., KINCAID, D.L., RIMON III, J., and RINEHART, W. Health Communication: Lessons From Family Planning and Reproductive Health. Westport, Connecticut, Praeger, 1997. 307 p.

157. PIOTROW, P.T. Informed choice: A responsibility that goes beyond the provider. In: Gallen, M.A., Lettenmaier, C., and Green, C. P. Counseling makes a difference. Population Reports, Series J, No. 35. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Nov. 1987. p. 15.

158. PIOTROW, P.T., TREIMAN, K.A., RIMON III, J.G., YUN, S.H., and LOZARE, B.V. Strategies for family planning promotion. Washington, D.C., World Bank, 1994. (World Bank Technical Paper No. 223) 58 p.

159. POLANCO, J.J. La dinamica de uso de anticoncepción en la Republica Dominicana: Un análisis de discontinuación, falla, y cambio de métodos. [SPA] [Contraceptive use dynamics in the Dominican Republic: An analysis of discontinuation, failure, and switching]. Calverton, Maryland, Macro International, Jun. 1994. (Seminario sobre la Dinamica Anticonceptiva en America Latina)

160. POPULATION COUNCIL (PC). A situation analysis of family welfare centers in Pakistan. New York, PC, Apr. 1993. 92 p.

161. POPULATION COUNCIL (PC). A situation analysis of family planning service delivery points in Ghana. New York, PC, 1994. 150 p.

*162. POPULATION COUNCIL (PC). The gap between reproductive intentions and behavior: A study of Punjabi men and women. Islamabad, Pakistan, PC, 1997. 78 p.

*163. POTTER, L.S. Oral contraceptive compliance and its role in the effectiveness of the method. In: Cramer, J.A. and Spilker, B., eds. Patient Compliance in Medical Practice and Clinical Trials. New York, Raven Press. 1991. p. 195-207.

*164. POTTER, L.S. How effective are contraceptives? The determination and measurement of pregnancy rates. Obstetrics and Gynecology 88(3 Suppl.): 13S-23S. Sep. 1996.

165. POTTER, L.S., OAKLEY, D., DE LEON-WONG, E., and CANAMAR, R. Measuring compliance among oral contraceptive users. Family Planning Perspectives 28(4): 154-158. Jul./Aug. 1996.

*166. POTTER, L.S., POTTS, M., GRUBB, G., and STEINER, M. What do we know about how women take the pill? 1991. 41 p. (Unpublished).

167. POTTS, M. and DENNY, C. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status. Drug Safety 13(6): 333-337. Dec. 1995.

168. PRATT, W.F. and BACHRACH, C.A. What do women use when they stop using the pill? Family Planning Perspectives 19(6): 257-266. Nov./Dec. 1987.

169. PULLAM, T.W. The relationship of service availability to contraceptive use in rural Guatemala. Aug. 1990. 50 p. (Unpublished).

170. RAHMAN, M., KHAN, M.A., CALDWELL, B.K., and KANE, T.T. Factors associated with reported side-effects of oral pills and injectibles in rural Bangladesh. In: Kane, T.T., Barkat-e-Khuda, and Phillips, J.F., eds. Reproductive Health in Rural Bangladesh: Policy and Programmatic Implications. Vol. 1. Dhaka, International Centre for Diarrhoeal Disease Research, Bangladesh. Jul. 1997. p. 191-216.

171. RAMSAY, S. UK “pill scare” led to abortion increase. Lancet 347(9008): 1109. Apr. 20, 1996.

172. RANDLE, N. Antibiotic- and anticonvulsant-induced oral contraceptive failure. Journal of Pharmacy Technology 1(6): 246-249. Nov./Dec. 1985.

173. REANEY, P. Half of UK women seeking abortion used contraception. (London). Reuters wire service. Nov. 13, 1999.

174. REES, H. Acquiring the pill: Safety issues. Reproductive Health Matters (3): 41-45. May 1994.

175. RINEHART, W., RUDY, S., and DRENNAN, M. GATHER guide to counseling. Population Reports, Series J, No. 48. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Dec. 1998. 32 p.

176. ROSENBERG, M. (Health Decisions, Inc.) [Factors related to OC use] Personal communication, May 2000.

177. ROSENBERG, M. [Length of oral contraceptive use] Personal communication, Dec. 1999.

178. ROSENBERG, M. and WAUGH, M.S. Causes and consequence of oral contraceptive noncompliance. American Journal of Obstetrics and Gynecology 180(2, Pt. 2): S276-S279. Feb. 1990.

*179. ROSENBERG, M.J., BURNHILL, M.S., WAUGH, M.S., GRIMES, D.A., and HILLARD, P.J. Compliance and oral contraceptives: A review. Contraception 52(3): 137-141. Sep. 1995.

180. ROSENBERG, M.J. and WAUGH, M.S. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. American Journal of Obstetrics and Gynecology 179(3, Pt. 1): 577-582. Sep. 1998.

*181. ROSENBERG, M.J., WAUGH, M.S., and LONG, S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. Journal of Reproductive Medicine 40(5): 355-360. May 1995.

182. ROSENBERG, M.J., WAUGH, M.S., and MEEHAN, T.E. Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation. Contraception 51(5): 283-288. May 1995.

183. ROSENFIELD, A.G. and LIMCHAROEN, C. Auxiliary midwife prescription of oral contraceptives: An experimental project in Thailand. In: Foreit, J.R. and Frejka, T., eds. Family Planning Operations Research: A Book of Readings. New York, Population Council. 1998. p. 71-81.

*184. ROSS, J. Contraception: Short-term vs. long-term failure rates. Family Planning Perspectives 21(6): 275-277. Nov./Dec. 1989.

185. SALTER, C., JOHNSTON, H.B., and HENGEN, N. Care for postabortion complications: Saving women's lives. Population Reports, Series L, No. 10. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Sep. 1997. 32 p.

186. SAMBISA, W. Contraceptive use dynamics in Zimbabwe: Discontinuation, switching, and failure. Calverton, Maryland, Macro International, Dec. 1996. (Zimbabwe Further Analysis) 24 p.

187. SAMUELS, S.E., STRYKER, J., and SMITH, M.D. Over-the-counter birth control pills: An overview. In: Samuels, S.E. and Smith, M.D., eds. The Pill: From Prescription to Over the Counter. Menlo Park, California, Kaiser Family Foundation. 1994. p. 1-19.

188. SCHAEFER, L. (Performance Improvement Consultative Group, JHPIEGO representative) [Revised definition of performance improvement] Personal communication, May 12, 2000.

189. SCHONDELMEYER, S.W. and JOHNSON, J.A. Economic implications of switching from prescription status. In: Samuels, S.E. and Smith, M.D., eds. The Pill: From Prescription to Over the Counter. Menlo Park, California, Kaiser Family Foundation. 1994. p. 189-235.

190. SCHULER, S.R. and HOSSAIN, Z. Family planning clinics through women's eyes and voices: A case study from rural Bangladesh. International Family Planning Perspectives 24(4): 170-175, 205. Dec. 1998. (Available: http://www.agi-usa.org/pubs/journals/2417098.html)

191. SEALZA, L. Factors affecting the family planning program drop-out rate in Bukidnon, Philippines. Manila, Research Institute for Mindanao Culture and Population Council, 1994. 81 p.

192. SEKADDE-KIGONDU, C., MWATHE, E.G., RUMINJO, J.K., NICHOLS, D., KATZ, K., JESSENCKY, K., and LIKU, J. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. East African Medical Journal 73(12): 786-794. Dec. 1996.

193. SERFATY, D. Medical aspects of oral contraceptive discontinuation. Advances in Contraception 8(Suppl. 1): 1-76. Oct. 1992.

194. SERFATY, D. Oral contraceptive compliance during adolescence. In: Creatsas, G., Mastorakos, G., and Chrousous, G.P., eds. Adolescent Gynecology and Endocrinology: Basic and Clinical Aspects. Annals of the New York Academy of Sciences. Vol. 816. Athens, Greece, New York Academy of Sciences. Jun. 17, 1997. p. 422-431.

195. SHAIN, R.N. and POTTS, M. Need for and acceptability of long-acting steroidal contraception. In: Zatuchni, G.L., Goldsmith, A., Shelton, J.D., and Sciarra, J.J., eds. Long-Acting Contraceptive Delivery System. Philadelphia, Harper and Row. 1984. p. 1-19.

196. SHANE, B. and CHALKLEY, K. From research to action: How operations research is improving reproductive health services. Washington, D.C., Population Reference Bureau, Mar. 1998. 40 p.

197. SHELTON, J.D. Precise pill-taking “behavior.” Jim Shelton's Pearls (Website). http://www.jhuccp.org/pearls/September99/sept399.stm. 1999.

198. SHELTON, J.D., ANGLE, M.A., and JACOBSTEIN, R.A. Medical barriers to access family planning. Lancet 340(8831): 1334-1335. Nov. 28, 1992.

*199. SHELTON, J.D., DAVIS, S., and MATHIS, J. Checklist for family planning service delivery, with selected linkages to reproductive health: Maximizing access and quality [brochure]. US Agency for International Development, 1998. 20 p.

*200. SHELTON, J.D. and DAVIS, S.S. Some priorities in maximizing access to and quality of contraceptive services. Advances in Contraception 12(3): 233-237. Sep. 1996.

201. SHENFIELD, G.M. Oral contraceptives: Are drug interactions of clinical significance? Drug Safety 9(1): 21-37. 1993.

202. SHENFIELD, G.M. and GRIFFIN, J.M. Clinical pharmacokinetics of contraceptive steroids: An update. Clinical Pharmacokinetics 20(1): 15-37. Jan. 1991.

203. SMITH, S.K., KIRKMAN, R.J., ARCE, B.B., MCNEILLY, A.S., LOUDON, N.B., and BAIRD, D.T. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalmic-pitutitary-ovarian axis. Contraception 34(5): 513-522. Nov. 1986.

204. SOBTI, J.C., RAO, A.R., DEERING, J., and SHAH, I.C. Project report on the involvement of Indian Medical Association members for promoting oral contraceptive pill and IUCD in Gujarat. Training of 1326 family planning counselors and 83 family planning consultants. New Delhi, IMA-AKN Sinha Institute of Continuing Medical and Health Education and Research, 1995. 64 p.

205. SOLO, J. and BILLINGS, D.L. Linkages with treatment for incomplete abortions improve family planning services in Kenya. Operations Research Alternatives, Washington, D.C. Population Council, Aug. 1998. p. 3. (Available: http://www.popcouncil.org/rhfp/alternatives/linkages.html)

206. SPARROW, M.J. Pregnancies in reliable pill takers. New Zealand Medical Journal 102(879): 575-577. Nov. 8, 1989.

207. SPARROW, M.J. Pill method failures in women seeking abortion: Fourteen years experience. New Zealand Medical Journal 111(1075): 386-388. Oct. 9, 1998.

208. STANBACK, J., QURESHI, Z., SEKADDE-KIGONDU, C., GONZALEZ, B., and NUTLEY, T. Checklist for ruling out pregnancy among family-planning clients in primary care. Lancet 354(9178): 566. Aug. 14, 1999.

209. STANBACK, J., THOMPSON, A., HARDEE, K., and JANOWITZ, B. Menstrual requirements: A significant barrier to contraceptive access in developing countries. Studies in Family Planning 28(3): 245-250. Sep. 1997.

210. STANG, A., Schwingl, P., and Rivera, R. New contraceptive eligibility checklists for combined oral contraceptives (COCs) and depot-medroxyprogesterone acetate (DMPA) provision in community-based services programmes. Bulletin of the World Health Organization 78(5). May 2000.

211. STARRS, A. The safe motherhood action agenda: Priorities for the next decade. Inter-Agency Group for Safe Motherhood, 1998. 98 p.

212. STEWART, M. Many pill users in Egypt lack adequate knowledge about how to take the pill. International Family Planning Perspectives 21(3): 123-124. Sep. 1995.

213. STONE, S.C. Should oral contraceptives be sold over-the-counter? American Journal of Gynecologic Health 7(2): 27-32. Mar./Apr.1993.

214. STOREY, D., BOULAY, M., KARKI, Y., HECKERT, K., and KARMACHARYA, D.M. Impact of the integrated Radio Communication Project in Nepal, 1994-1997. Journal of Health Communication 4: 271-294. 1999.

215. SULLIVAN, R., BRECHIN, S., and LACOSTE, M. Structured on-the-job training: Innovations in international health training. In: American Society for Training and Development (ASTD), ed. Linking HRD Programs with Organizational Strategy. ASTD. p. 155-179. (Available: http://www.reproline.jhu.edu/english/3improve/3ojt/ojt1.htm)

216. SULLIVAN, H., FURNISS, H., SPONA, J., and ELSTEIN, M. Effect of 21-day and 24-day OC regimens containing gestodene (60 mg) and ethinyl estradiol (15 mg) on ovarian activity. Fertility and Sterility 72(1): 115-120. Jul. 1999.

217. SUYONO, H., HENDRATA, L., and ROHDE, J. The family planning movement in Indonesia. In: Rohde, J., Chatterjee, M., and Morley, D., eds. Reaching Health for All. New Delhi, Oxford University Press. 1993. p. 482-500.

218. SZAREWSKI, A. and GUILLEBAUD, J. Contraception: A User's Handbook. Oxford, Oxford University Press, 1994. 264 p. 219. TAYOB, Y., ROBINSON, G., ADAMS, J., NYE, M., WHITELAW, N., SHAW, R.W., JACOBS, H.S., and GUILLEBAUD, J. Ultrasound appearance of the ovaries during the pill-free interval. British Journal of Family Planning 16(3): 94-96. Oct. 1990.

220. TECHNICAL GUIDANCE/COMPETENCE WORKING GROUP. Recommendations for updating selected practices in contraceptive use, Volume I. Curtis, K.M. and Bright, P.L., eds. US Agency for International Development, World Health Organization, Nov. 1994. 130 p. (Available: http://www.reproline.jhu.edu/english/6read/6multi/6tgwg/6tgwg.htm, Accessed Aug. 10, 1999) 221. TECHNICAL GUIDANCE/COMPETENCE WORKING GROUP. Recommendations for updating selected practices in contraceptive use, Volume II. Gaines, M., ed. US Agency for International Development, World Health Organization, Sep. 1997. 260 p. (Available: http://www.reproline.jhu.edu/english/6read/6multi/6tgwg/6tgwg.htm, Accessed Aug. 10, 1999)

222. TOWNSEND, S. Attitudes, regulations hinder use of the pill. Network 13(3): 6-10. Research Triangle Park, North Carolina, Family Health International. Mar. 1993.

223. TRUSSELL, J. Contraceptive efficacy. In: Hatcher, R., Trussell, J., Stewart, F., Cates Jr., W., Stewart, G.K., Guest, F., and Kowal, D., eds. Contraceptive Technology. 17th ed. New York, Ardent Media. 1998. p. 779-791.

224. TRUSSELL, J., STEWART, F., POTTS, M., GUEST, F., and ELLERTSON, C. Should oral contraceptives be available without prescription? American Journal of Public Health 83(8): 1094-1099. Aug. 1993.

225. TRUSSELL, J. and VAUGHAN, B. Contraceptive failure, method-related discontinuation and resumption of use: Results from the 1995 National Survey of Family Growth. Family Planning Perspectives 31(2): 64-72, 93. Mar./Apr. 1999. (Available: http://www.agi-usa.org/pubs/journals/3106499.html) 226. TSUI, A.O. and OCHOA, L.H. Service proximity as a determinant of contraceptive behavior: Evidence from cross-national studies of survey data. Chapel Hill, North Carolina, Carolina Population Center, Mar. 1989. (Carolina Population Center Papers No. 89-05) 43 p.

*227. TWEEDIE, I., OFORI, J., and GLASS, W. Family planning continuation among MOH defaulters in Ghana. Baltimore, Ghana Ministry of Health/Health Education Unit, and Johns Hopkins School of Public Health Center for Communication Programs, Apr. 1996. 38 p. (Draft preliminary report).

228. TWUM-BAAH, K.A. and STANBACK, J. Provider rationales for restrictive family planning service practices in Ghana [Fact sheet]. Ghana Statistical Service, Family Health International, Nov. 1996. 3 p.

229. UNITED NATIONS FUND FOR CHILDREN (UNICEF). WHO/UNICEF/UNFPA workshop on systematizing experiences in implementing women-friendly health services. UNICEF (Website). http://www.unicef.org/safe/ Jan. 26-28, 1999. (Executive summary report)

230. US FOOD AND DRUG ADMINISTRATION. FDA to hold public meeting on regulation of OTC products. (Website). http://www.fda.gov/bbs/topics/NEWS/NEW00725.html. Apr. 27, 2000.

231. WAHAB, M. and KILLICK, S. Oral contraceptive knowledge and compliance in young women. British Journal of Family Planning 22(4): 170-174. Jan. 1997.

232. WANG, C.C., VITTINGHOFF, E., HUA, L.S., YUN, W.H., and RONG, Z.M. Reducing pregnancy and induced abortion in China: Family planning with husband participation. American Journal of Public Health 88(4): 646-648. Apr. 1998.

233. WANG, E., SHI, S., CEKAN, S.Z., LANDGREN, B.M., and DICZFALUSY, E. Hormonal consequences of “missing the pill.” Contraception 26(6): 545-565. Dec. 1982.

*234. WEAVER, K. and GLASIER, G. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: A literature review. Contraception 59(2): 71-78. Feb. 1999.

235. WEISBERG, E. OCs and community failure rate: What can the GP do to reduce it? Current Therapeutics 35(9): 47-48, 51-52. Sep. 1994.

236. WELLS, E., CROOK, B., and MULLER, N. Emergency contraception: A resource manual for providers. Seattle, Washington, Program for Appropriate Technology in Health, May 1997. 34 p.

237. WESTCOTT, M., KOVACS, G., and JARMAN, H. Attitudes to oral contraception in family planning attenders. British Journal of Family Planning 18(3): 85-88. Oct. 1992.

238. WESTOFF, C.F. and BANKOLE, A. Mass media and reproductive behavior in Africa. Calverton, Maryland, Macro International, Apr. 1997. (Demographic and Health Surveys Analytical Report No. 2) 39 p.

239. WESTOFF, C.F. and BANKOLE, A. Mass media and reproductive behavior in Pakistan, India and Bangladesh. Calverton, Maryland, Macro International, May 1999. (Demographic and Health Surveys Analytical Report No. 10) 32 p.

240. WILLIAMS-DEANE, M. and POTTER, L.S. Current oral contraceptive use instructions: An analysis of patient package inserts. Family Planning Perspectives 24(3): 111-115. May/Jun. 1992.

241. WINIKOFF, B. Extra contraceptive protection during combined oral contraceptive use and antibiotics. In: Weaver, K. and Glasier, A. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill. Contraception 59(2):71-78. 1999.

242. WOOD, R., BOTTING, B., and DUNNELL, K. Trends in conceptions before and after the 1995 pill scare. Office for National Statistics, United Kingdom, Autumn, 1997. 89 p.

243. WORLD HEALTH ORGANIZATION (WHO). Abortion. A tabulation of available data on the frequency and mortality of unsafe abortion. Geneva, WHO, 1997.

*244. WORLD HEALTH ORGANIZATION (WHO). Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use. Geneva, WHO, 1996. 143 p.

*245. WORLD HEALTH ORGANIZATION (WHO). Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use. 2nd ed. Geneva, WHO, May 2000. (Draft).

246. WORLD HEALTH ORGANIZATION (WHO) and INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS (FIGO). Community-based services for family planning: The role of the medical profession. International Journal of Gynecology and Obstetrics 49(1): 85. Apr. 1995.

247. YESHAYA, A., ORVIETO, R., KAPLAN, B., BAR-HAVA, I., BAR, J., and BEN-RAFAEL, Z. Flexible starting schedule for oral contraception: Effect on the incidence of breakthrough bleeding and compliance. European Journal of Contraception and Reproductive Health Care 3(3): 121-123. Sep. 1998.

248. YESHAYA, A., ORVIETO, R., KAUSCHANSKY, A., DICKER, D., BAR-HAVA, I., and BEN-RAFAEL, Z. A delayed starting schedule of oral contraception: The effect on the incidence of breakthrough bleeding and compliance in women. European Journal of Contraception and Reproductive Health Care 1(3): 263-265. Sep. 1996.

249. YOUNGKIN, E.Q., DAVIS, M.S., and KOLB, K.W. Making oral contraceptives available over-the-counter [letter]. Nurse Practitioner 21(3): 13, 133-134, 143-144. Mar. 1996.

250. ZAVALA, A.S., PEREZ-GONZALES, M., MILLER, P., WELSH, M., WILKINS, L.R., and POTTS, M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Studies in Family Planning 18(5): 284-290. Sep./Oct. 1987.

ADDENDA

251. BELFIELD, T. (Family Planning Association (UK)) [Practical use of seven-day guidelines] Personal communication, Jun. 16, 2000.

252. GESTODENE STUDY GROUP 324. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60mg/ethinlyestradiol 15mg and a 21-day regimen of desogestrel 150mg/ethinylestradiol 20mg. European Journal of Contraception and Reproductive Health Care 4(Suppl. 2): 17-25. Nov. 1999.

253. HANSEN, T.H. and LUNDVALL, F. Factors influencing the reliability of oral contraceptives. Acta Obstetricia et Gynecologica Scandinavica 76(1): 61-64. Jan. 1997.

254. KAKOURIS, H. and KOVACS, G.T. Pill failure and non-use of secondary precautions. British Journal of Family Planning 18(2): 41-44. Jul. 1992.

255. KOVACS, G.T., RIDDOCH, G., DUNCOMBE, P., WELBERRY, L., CHICK, P., and WEISBERG, E. Inadvertent pregnancies in oral contraceptive users. Medical Journal of Australia 150(10): 549-551. May 15, 1989.

256. PSL GROUP. Minesse (Gestodene/Ethinyl Estradiol), low-dose contraceptive, approved in Europe. Doctor's Guide. Mar. 23, 2000. (Available: http://www.pslgroup.com/dg/19396e.htm) 257. WORLD HEALTH ORGANIZATION (WHO). Overcoming antimicrobial resistance. Geneva, WHO, 2000.

258. YIMIN, C., WEI, Z., ZHIMIN, L., YANG, Z., and AIYING, W. Contraceptive practices of women requesting termination of pregnancy: A study from China. Contraception 55(1): 15-17. Jan. 1997.

259. YOUNG, L.K., FARQUHAR, C.M., MCCOWAN, L.M., ROBERTS, H.E., and TAYLOR, J. The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic. New Zealand Medical Journal 107(978): 189-192. May 25, 1994.

ISSN 0887-0241

Palavras chave: oral, health, m, p, family, planning, population, family planning, j, apr, 1998, international, contraceptive, health international, network, 1996, contraception, family health international, barnett b, oral contraceptives,

Divulgação



Publicidade

conteúdos relacionados
Search_LibdocFree @SearchWordsAux='09 - Referências Bibliográficas oral, health, m, p, family, planning, population, family planning, j, apr, 1998, international, contraceptive, health international, network, 1996, contraception, family health international, barnett b, oral contraceptives, ',@type='ARTICLE', @libdocidant=14397, @max_rows=10, @key_rank=0
Artigo / Publicado em 22 de agosto de 2000

11 - Bibliografia - 1ª Parte

Artigo / Publicado em 22 de agosto de 2000

Bibliografia - 1ª Parte

Artigo / Publicado em 17 de fevereiro de 2003

Referências Bibliográficas - 1ª Parte

Artigo / Publicado em 22 de agosto de 2000

09 - Bibliografia - 1ª Parte

Artigo / Publicado em 22 de agosto de 2000

Bibliografia - 1ª Parte

Artigo / Publicado em 13 de novembro de 2000

Bibliografia - 3ª Parte

Notícia / Publicada em 23 de fevereiro de 2016

Novo aplicativo dá suporte à saúde bucal para uso por médicos de família

Notícia / Publicada em 4 de dezembro de 2008

Métodos de medicina complementar e alternativa para redução da PA

Notícia / Publicada em 14 de outubro de 2008

Ingestão de folato, marcadores do nível de folato e fendas orais

Notícia / Publicada em 19 de setembro de 2008

Uso de esteróides orais no tratamento inicial da lombalgia aguda: é justificável?



Assinantes


Esqueceu a senha?